Radiance's new catheter designs in BRITE trials:
This article was originally published in Clinica
Radiance Medical Systems has gained permission from the US FDA to use new catheter designs of its monorail RDX coronary radiation delivery system in its BRITE II and BRITE-SVG in-stent restenosis studies (see Clinica No 942, p 22). The Irvine, California company says it has enhanced the materials and design features of the RDX to provide a lower profile, more flexible device, with a longer shelf-life. An over-the-wire version of the RDX catheter has also been approved for use in both trials.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.